dupilumab
sanofi,regeneron
['dupilumab', 'derm', 'dupixent']
dupixent (dupilumab) late-breaking data at aad show significant improvements in signs and symptoms of moderate-to-severe atopic hand and foot dermatitis 
🚨 🚨 Get Profitable Stock Signal Alerts 🚨 🚨 📱 📱 Sent Directly Via Text Message 📱 📱 Click Link To Subscribe 👇🏻👇🏻